NCT07200388

Brief Summary

This study aims to understand how the ability to identify and describe specific emotions (called "emotional granularity") influences coping and adaptation ("resilience") in young and middle-aged colorectal cancer survivors. The main questions to be answer are:

  1. 1.How does emotional granularity help build resilience during cancer recovery?
  2. 2.How does emotion regulation contribute to resilience building?
  3. 3.What specific emotional needs and challenges do survivors experience?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
236

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

September 30, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

September 17, 2025

Last Update Submit

September 27, 2025

Conditions

Keywords

Emotional GranularityPsychological ResilienceMixed Methods ResearchYoung and Middle-Aged AdultsColorectal NeoplasmsEmotional Regulation

Outcome Measures

Primary Outcomes (1)

  • Level of Resilience

    Resilience will be measured by the total score on the Chinese version of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Scores range from 0 to 40, with higher scores indicating higher levels of resilience.

    Baseline (Day 1, at questionnaire completion for each participant)

Secondary Outcomes (2)

  • Emotional Granularity Score

    Baseline (Day 1, at questionnaire completion for each participant)

  • Emotion Regulation Difficulties Score

    Baseline (Day 1, at questionnaire completion for each participant)

Other Outcomes (1)

  • Qualitative Themes on Emotional Needs

    Post-questionnaire phase (within approximately 2-6 weeks after baseline, depending on scheduling of interviews)

Study Arms (1)

Young and Middle-Aged CRC Survivors

This single cohort consists of young and middle-aged adult survivors of colorectal cancer. All participants will complete the quantitative survey phase. A subset of participants, purposively sampled based on their survey scores, will then be invited to participate in the qualitative interview phase. There is no intervention administered; this is an observational study examining the relationships between emotional granularity, emotion regulation, and resilience.

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of samples and data obtained from three major regional tertiary hospitals in Suzhou, Jiangsu Province: 1. The First Affiliated Hospital of Soochow University: A leading comprehensive tertiary Grade A hospital and a major clinical, teaching, and research center in the region. 2. The Second Affiliated Hospital of Soochow University: Another key comprehensive tertiary Grade A hospital providing high-level medical services to the urban population. 3. Kunshan First People's Hospital Affiliated to Jiangsu University: A premier tertiary Grade A hospital representing the high-quality healthcare infrastructure of county-level cities within the Suzhou administrative area. This selection encompasses top-tier medical institutions from both the central urban district of Suzhou and a developed county-level city (Kunshan), ensuring a representative and diverse sample of the patient population and healthcare delivery within the Suzhou region.

You may qualify if:

  • Young and middle-aged adult patients (age in the range of 18-60 years);
  • Patients diagnosed with CRC;
  • Patients have completed primary treatments (e.g., surgery, chemotherapy, and/or radiotherapy) without experiencing a recurrence of CRC;
  • Patients able to use a smartphone and agree to participate in the study.

You may not qualify if:

  • Patients who have not been informed of their cancer diagnosis due to family decision to withhold information;
  • Patients suffering from severe conditions that may affect participation or assessment, such as significant cognitive impairment, psychiatric disorders, or communication disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kunshan First People's Hospital Affiliated to Jiangsu University

Suzhou, Jiangsu, 215000, China

Location

The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215000, China

Location

The First Affiliated Hospital of Soochow University

Suzhu, Jiangsu, 215000, China

Location

MeSH Terms

Conditions

Colorectal NeoplasmsEmotional Regulation

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesSelf-ControlSocial BehaviorBehavior

Central Study Contacts

Joyce Oi Kwan Chung, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 17, 2025

First Posted

October 1, 2025

Study Start

September 30, 2025

Primary Completion

March 1, 2026

Study Completion

April 1, 2026

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations